Graham Juan

CIK 00018792232 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001879223

Recent Transactions

41 trades

Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2025-03-28$2.25/sh+33,333→ 35,354 total
Award
Perspective Therapeutics, Inc.$CATX
Stock option (right to buy)
2025-01-06+400,000→ 400,000 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-12-07$0.34/sh−1,066→ 164,863 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-12-06$0.34/sh−1,446→ 165,929 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-09-07$0.39/sh−1,065→ 167,375 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-09-06$0.39/sh−16,050→ 168,440 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-06-07$1.10/sh−1,182→ 184,490 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-06-06$1.19/sh−17,797→ 185,672 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-03-07$1.79/sh−1,181→ 203,469 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-03-06$1.87/sh−20,327→ 204,291 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-03-06$1.87/sh−422→ 204,650 total
Award
FIBROGEN INC$FGEN
Common Stock
2024-03-06+781→ 205,072 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2024-02-21+260,000→ 260,000 total
Award
FIBROGEN INC$FGEN
Common Stock
2024-02-21+52,000→ 224,618 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2023-12-07$0.62/sh−1,085→ 172,618 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2023-12-06$0.58/sh−15,573→ 173,703 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2023-09-07$0.99/sh−1,096→ 189,276 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2023-09-06$0.96/sh−711→ 190,372 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2023-08-30+220,000→ 220,000 total
Award
FIBROGEN INC$FGEN
Common Stock
2023-08-30+120,000→ 191,083 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-06-07$16.95/sh−1,050→ 71,818 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-06-07$17.04/sh−735→ 71,083 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-03-10$20.20/sh−1,456→ 75,212 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-03-10$20.20/sh−2,344→ 72,868 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-03-10$20.20/sh−1,112→ 76,668 total
Award
FIBROGEN INC$FGEN
Common Stock
2023-03-08+4,668→ 77,780 total
Award
FIBROGEN INC$FGEN
Common Stock
2023-03-08+2,899→ 73,112 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-03-08$21.16/sh−2,749→ 70,213 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2023-02-21+42,000→ 42,000 total
Award
FIBROGEN INC$FGEN
Common Stock
2023-02-21+25,000→ 72,962 total
Sale
FIBROGEN INC$FGEN
Common Stock
2022-12-12$14.50/sh−1,407→ 47,962 total
Sale
FIBROGEN INC$FGEN
Common Stock
2022-12-12$14.50/sh−1,407→ 53,703 total
Sale
FIBROGEN INC$FGEN
Common Stock
2022-12-09$14.89/sh−781→ 49,369 total
Sale
FIBROGEN INC$FGEN
Common Stock
2022-12-09$14.90/sh−781→ 55,110 total
Sale
FIBROGEN INC$FGEN
Common Stock
2022-12-08$14.84/sh−5,263→ 50,628 total
Sale
FIBROGEN INC$FGEN
Common Stock
2022-12-08$15.47/sh−478→ 50,150 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2022-09-07$12.62/sh−3,009→ 55,891 total
Award
FIBROGEN INC$FGEN
Common Stock
2022-02-14+22,500→ 58,900 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2022-02-14+37,500→ 37,500 total
Award
FIBROGEN INC$FGEN
Common Stock
2021-09-07+35,000→ 36,400 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2021-09-07+196,000→ 196,000 total

Companies

Recent Filings

Address

C/O PERSPECTIVE THERAPEUTICS, INC. 2401 ELLIOTT AVENUE, SUITE 320

SEATTLE, WA, 98121

View on SEC.gov